Obsessive-Compulsive Disorder Clinical Trial
— BIPBJÖRNOfficial title:
Increased Access to Psychological Treatment for Children and Adolescents Through Internet-delivered CBT - a Pragmatic Evaluation Within Regular Health Care in a Rural Area of Sweden
Verified date | October 2023 |
Source | Karolinska Institutet |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this study is to test internet-delivered cognitive behavior therapy for children and adolescents with anxiety disorders and obsessive-compulsive disorder in a routine clinical setting in a rural part of Sweden.
Status | Completed |
Enrollment | 83 |
Est. completion date | December 2022 |
Est. primary completion date | April 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 8 Years to 17 Years |
Eligibility | Inclusion Criteria: - Fulfills diagnostic criteria for an anxiety disorder or OCD - Access to a computer and internet connection - Read and speak Swedish Exclusion Criteria: - ICBT is currently not assessed to be a suitable treatment - Acute psychiatric problem (eg. severe depression or suicidality) - Current psychosocial problems in the family (i.e substance abuse, abuse, neglect) |
Country | Name | City | State |
---|---|---|---|
Sweden | BUP Jämtland Härjedalen | Östersund | Region Jämtland Härjedalen |
Lead Sponsor | Collaborator |
---|---|
Karolinska Institutet |
Sweden,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | CGI-S | Clinical Global Impression - Severity | 24 weeks from baseline | |
Secondary | CGI-S | Clinical Global Impression - Severity | 12 weeks from baseline | |
Secondary | CGI-I | Clinical Global Impression - Improvement | 12 and 24 weeks from baseline | |
Secondary | CGAS | Children's Global Assessment Scale | 12 and 24 weeks from baseline | |
Secondary | CY-BOCS | Children's Yale Brown Obsessive Compulsive Scale | 12 and 24 weeks from baseline | |
Secondary | RCADS | Revised Children's Anxiety and Depression Scale | 12 and 24 weeks from baseline | |
Secondary | EWSAS | Education, Work and Social Adjustment Scale - Child and parent versions | Week 1 through 12 + 24 weeks from baseline | |
Secondary | Patient satisfaction | Questionnaire on child- and parent rated treatment satisfaction | 12 weeks from baseline | |
Secondary | Adverse events | Unintended treatment effects - child and parent version | 12 weeks from baseline |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04934007 -
Bilateral Lateral OFC rTMS in Obsessive Compulsive Disorder
|
N/A | |
Recruiting |
NCT04071990 -
Family Involvement in CBGT of OCD: a Randomized Controlled Trial
|
N/A | |
Completed |
NCT02541968 -
Internet-based vs Face-to-face Cognitive Behavioural Therapy for Obsessive-compulsive Disorder
|
N/A | |
Recruiting |
NCT05651295 -
A Precision Medicine Approach to Target Engagement for Emotion Regulation
|
N/A | |
Recruiting |
NCT05391503 -
Light Therapy for Obsessive-compulsive Disorder (OCD)
|
N/A | |
Recruiting |
NCT04539951 -
Pragmatic Trial of Obsessive-compulsive Disorder
|
Phase 2 | |
Completed |
NCT03416504 -
Methods for Managing Intrusive Thoughts
|
N/A | |
Not yet recruiting |
NCT06029738 -
Effect on Obsessive-Compulsive Beliefs and Symptoms of MCT-OCD
|
N/A | |
Recruiting |
NCT02844049 -
European Study of Quality of Life in Resistant OCD Patients Treated by STN DBS
|
N/A | |
Completed |
NCT02911324 -
Cannabinoid Medication for Adults With OCD
|
Phase 1/Phase 2 | |
Terminated |
NCT02909660 -
What Are You Looking for? Psychometric and Experimental Analyses of Reassurance Seeking in Obsessive-compulsive Disorder
|
N/A | |
Terminated |
NCT02234011 -
A Trial of Intranasal Ketamine for the Treatment of Obsessive-Compulsive Disorder
|
Phase 2 | |
Completed |
NCT02217995 -
Mindfulness-Based Cognitive Therapy in a Clinical Sample of OCD Patients
|
N/A | |
Withdrawn |
NCT01953042 -
Benefits of a Psychoeducation Program for Those Awaiting Treatment for OCD and OCD Spectrum Disorders
|
N/A | |
Completed |
NCT02655926 -
Deep Brain Stimulation for Severe Obsessive Compulsive Disorder
|
N/A | |
Terminated |
NCT00758966 -
Naltrexone SR and Fluoxetine Combination Therapy in Subjects With Obsessive-Compulsive Disorder
|
Phase 2 | |
Completed |
NCT00742664 -
Behavioral Treatment of Obsessive-Compulsive Symptoms in Youth With Prader-Willi Syndrome: A Pilot Project
|
Phase 1/Phase 2 | |
Completed |
NCT04919785 -
Deep Brain Stimulation in Severe Obsessive-compulsive Disorder
|
N/A | |
Completed |
NCT00523718 -
Riluzole Augmentation in Treatment-refractory Obsessive-compulsive Disorder
|
Phase 2 | |
Completed |
NCT00074815 -
Treatment of Obsessive Compulsive Disorder in Children
|
Phase 3 |